Homozygous familial hypercholesterolaemia is a rare inherited condition with an incidence of approximately one in a million. It is associated with severe premature atherosclerosis and early death from cardiovascular complications. The results ofliver transplantation reported to date have suggested only partially effective reduction of the hypercholesterolaemia.
laemia.
Three boys with familial hypercholesterolaemia, aged 10-0 to 151 years, received liver grafts at Addenbrooke's Hospital. Their untreated fasting lipid concentrations were grossly raised. All three had angiographic evidence of coronary atheroma and two had exertional angina. One child had such severe atheroma that coronary artery bypass surgery was considered necessary before liver transplantation. All three had straightforward operative and postoperative courses and their lipid concentrations returned rapidly to normal. One boy developed chronic rejection requiring retransplantation. Currently all three boys are well, on normal diets, and with normal liver function.
It is concluded that (1) liver transplantation offers highly effective treatment for this lethal condition, (2) timing the operation is difficult but it should be undertaken before coronary artery disease has progressed too far (when combined liver and heart transplantation may be the only possibility), and (3) We describe three children in whom liver transplantation fully corrected the lipid abnormality.
Case reports PATIENT 1 This English boy developed xanthomata at 11 months of age and was found to have the typical lipid profile of homozygous familial hypercholesterolaemia. Initially he was treated with a low fat diet only but from the age of 9 years cholestyramine and nicotinic acid were added. Coronary angiography was normal at that time but when repeated four years later showed a 30% stenosis of the proximal left descending coronary artery. He remained asymptomatic and no ischaemic changes were seen on an electrocardiogram (ECG). His treatment was intensified and for two years he had weekly plasma exchanges. Although this produced a satisfactory fall in lipid concentrations he found the treatment extremely burdensome and it was complicated by multiple central line infections. He was therefore referred for consideration of liver transplantation.
He received a whole liver graft in October 1990 and had an uncomplicated perioperative course. The donor was cytomegalovirus positive and the patient developed cytomegalovirus hepatitis which resolved fully after a course of ganciclovir. His lipid profile and liver function returned to normal two weeks after transplantation (table and figure). He was well and had a normal lipid profile and normal liver function 3-8 years after the operation. PATIENT 2 This Asian son of a first cousin marriage developed xanthomata at the age of 6 years and was found to have familial hypercholesterolaemia. In spite of treatment with a low fat diet, cholestyramine and simvastatin, his cholesterol remained greatly raised. Coronary angiography at the age of 9 showed atheromatous changes of the left coronary artery and the descending aorta and also a 50-70% stenosis of the inferior mesenteric artery. There was a chronic dissection of the aorta below the renal arteries which was presumed to have occurred as a complication of angiography. He was referred for transplantation.
He is Greek boy developed extensive xan-found in approximately one in 500 of the imata from the age of 3 years and familial population. A number of mutant alleles have ercholesterolaemia was diagnosed. He was been identified, the commonest resulting in Lted with a low fat diet and cholestyramine absence of the LDL receptors, while others this had little effect on his cholesterol con-result in reduced numbers or abnormal functrations. From 11 years of age he developed tion of receptors. Heterozygotes have total rtional angina and was referred to the serum cholesterol concentrations approximpton Hospital in London. An exercise mately double the normal range (7-3 mmol/l).
:ssed ECG showed severe ischaemic changes In the homozygous state, which occurs in only l coronary angiography demonstrated one in a million of the population, the cholesterol concentrations are much higher, ranging from approximately 18 to 26 mmol/l. of life. The manifestations may include corneal arcus and the formation of tuberous xanthoma over tendons and pressure areas. Treatment options for familial hypercholesterolaemia include diet, drugs, plasmapheresis, bypass surgery, and liver transplantation.5 Since the gene has been localised, gene therapy may become the treatment of choice for the future. The first patient who has received successful ex vivo gene therapy has recently been reported.6
Diet is of most benefit to patients with mildly raised serum lipids and has only a supporting role in the treatment of familial hypercholesterolaemia. Drugs used in the treatment of hypercholesterolaemia are of two main types: bile acid sequestrants and LDL receptor modifying agents. Bile acid sequestrants lower serum cholesterol by up to 20% and therefore are used as an adjunctive treatment in familial hypercholesterolaemia. They are also unpalatable, cause steatorrhoea, and prevent absorption of various nutrients, particularly the fat soluble vitamins. LDL receptor modifying agents are ineffective in this condition because the receptors are absent in homozygous familial hypercholesterolaemia.
Plasmapheresis In conclusion, liver transplantation offers a highly effective treatment for this lethal condition and seems likely to remain the treatment of choice until gene therapy becomes a viable alternative. The timing of the operation is difficult but it should be considered once there is angiographic evidence of atheromatous disease, even in the absence of exertional angina. In well grown children with no previous abdominal surgery, the immediate risks of liver transplantation are low but long term complications such as chronic rejection remain a danger. After successful transplantation there may be a remarkable regression of established atheromatous lesions. 
